Pharmaceutical group ยท United States
Abbott
A group of 29 companies with 577 medicines in 9 countries.
Group structure
29 companies in 12 countries
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท United States
A group of 29 companies with 577 medicines in 9 countries.
29 companies in 12 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 577
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| A-POXIDE10mg | 25mg | 5mg ยท Capsule | Chlordiazepoxide | United States | Not marketed | 1977 |
| ALIVETORE | Etoricoxib | Brazil | Authorised | 2024 |
| AMINOSYN 3.5% IN PLASTIC CONTAINER3.5% (3.5gm/100ml) ยท Injectable | Amino acids | United States | Not marketed | |
| AMINOSYN 3.5% M IN PLASTIC CONTAINER3.5%; 21mg/100ml; 40mg/100ml; 128mg/100ml; 234mg/100ml ยท Injectable | Amino acids, Magnesium acetate, Phosphoric acid, Potassium acetate, Sodium chloride | United States | Not marketed | |
| AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | |
| AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | |
| AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | |
| AMINOSYN-HBC 7% IN PLASTIC CONTAINER7% (7gm/100ml) ยท Injectable | Amino acids | United States | Not marketed | |
| AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 3.5% IN PLASTIC CONTAINER3.5% (3.5gm/100ml) ยท Injectable | Amino acids | United States | Not marketed | |
| AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml ยท Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | United States | Not marketed | 1986 |
| AMINOSYN II 3.5% M IN PLASTIC CONTAINER3.5%; 32mg/100ml; 128mg/100ml; 222mg/100ml; 49mg/100ml ยท Injectable | Amino acids, Magnesium acetate, Potassium acetate, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | United States | Not marketed | |
| AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml; 51mg/100ml; 22.4mg/100ml; 261mg/100ml; 205mg/100ml ยท Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Potassium phosphate, Dibasic, Sodium chloride | United States | Not marketed | 1986 |
| AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER4.25%; 10gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER4.25%; 20gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER4.25%; 10gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml | 4.25%; 5gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml ยท Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | United States | Not marketed | 1986 |
| AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml; 51mg/100ml; 22.4mg/100ml; 261mg/100ml; 205mg/100ml ยท Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Potassium phosphate, Dibasic, Sodium chloride | United States | Not marketed | 1986 |
| AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER5%; 25gm/100ml ยท Injectable | Amino acids, Dextrose | United States | Not marketed | 1986 |
| Batrevac, suspensie voor injectie in voorgevulde spuit 0,5 mlSuspensie voor injectie | A-darwin-1454-2025 -achtige stam, A-missouri-11-2025 pdm09-achtige stam, B-tokyo-eis13-175-2025-achtige stam | Netherlands | Authorised | 1999 |
| BETASERC | Betahistine | Brazil | Authorised | 2011 |
| BETASERC 24 TABLET 24 mg24 mg ยท Tablet | Betahistine | Singapore | Authorised | 2003 |
| BETASERC TABLETS 16 mg16 mg ยท Tablet | Betahistine | Singapore | Authorised | 2000 |
| BISINTEX | Trastuzumab | Brazil | Authorised | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 267 | 45 | 222 | CompaniesAll medicines |
| Canada | 112 | 0 | 112 | CompaniesAll medicines |
| Saudi Arabia | 71 | 71 | 0 | CompaniesAll medicines |
| United States | 60 | 60 | 0 | CompaniesAll medicines |
| Singapore | 45 | 45 | 0 | CompaniesAll medicines |
| Netherlands | 16 | 16 | 0 | CompaniesAll medicines |
| European Union (EMA) | 4 | 0 | 4 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
| Taiwan | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Licence: Companies House statutory public-register use; OGL 3.0 for Crown-created website material
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: ยฉ OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Oficiul Naศional al Registrului Comerศului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Licence: Taiwan Government Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.